Getting Real with RWE Article Getting Real with RWE By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…Certara2020年11月20日
The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal White Paper The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal Certara2020年10月28日
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU On-Demand Webinar SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU In this webinar, our experts provided an overview of the SNDS and the key working…Certara2020年10月20日
Payment Pressures in U.S. Specialty: Status quo and outlook for future financing On-Demand Webinar Payment Pressures in U.S. Specialty: Status quo and outlook for future financing To allow for the optimal positioning of your product, portfolio, or company, it is critical…Certara2020年9月15日
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? オンデマンド・ウェビナー 希少疾患治療薬のジレンマ:価値は高いが、価格も高く、アクセスは限定的? This webinar will explain how pricing has evolved for the rare disease drug market and…Certara2020年2月19日
Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development Blog Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…Certara2019年12月19日
ICER’s Unsupported Drug Price Increase Report: An Analysis Blog ICER’s Unsupported Drug Price Increase Report: An Analysis We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported…Certara2019年10月24日
Innovative Solutions for Fast-Tracking Drugs for Rare Diseases On-Demand Webinar 希少疾患の治療薬を迅速に開発するための革新的なソリューション This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…Certara2019年8月10日
Evidence and Access Overview Brochure サターラのエビデンス&アクセスの概要 Discover Certara’s holistic approach to market access.Certara2019年5月21日